Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection

BACKGROUND: Rifabutin has been found to be effective in multi-resistant patients after various treatment cycles for Helicobacter pylori (HP) infection, but it has not been analysed as a second-line treatment. Therefore, we seek to compare the effectiveness of a treatment regimen including rifabutin...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro-Jarabo, José M, Fernández, Nuria, Sousa, Francisca L, Cabrera, Encarnación, Castro, Manuel, Ramírez, Luz M, Rivera, Robin, Ubiña, Esther, Vera, Francisco, Méndez, Isabel, Rivas-Ruiz, Francisco, Moreno, José L, Perea-Milla, Emilio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1941741/
https://www.ncbi.nlm.nih.gov/pubmed/17651479
http://dx.doi.org/10.1186/1471-230X-7-31

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1941741/
https://www.ncbi.nlm.nih.gov/pubmed/17651479
http://dx.doi.org/10.1186/1471-230X-7-31

Ejemplares similares